Acute adenosine treatment is effective in augmentation of ischemic tolerance in muscle flaps in the pig

Plastic and Reconstructive Surgery

Volumn 99, Issue 1, 1997, Pages 172-182

  Forrest, Christopher R ^b   Neligan, Peter ^b   Zhong, Anguo ^b   He, Wei ^b   Yang, Richard Z ^b   Pang, Cho Y ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE TRIPHOSPHATE; TETRAZOLIUM;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; GRACILIS MUSCLE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFARCTION; INTRAARTERIAL DRUG ADMINISTRATION; ISCHEMIA; LATISSIMUS DORSI FLAP; MALE; MEAN ARTERIAL PRESSURE; MUSCLE BIOPSY; MUSCLE BLOOD FLOW; MUSCLE FLAP; MUSCLE NECROSIS; NONHUMAN; PRIORITY JOURNAL;

ADENOSINE; ADENOSINE TRIPHOSPHATE; ANIMALS; INFARCTION; MUSCLE, SKELETAL; SURGICAL FLAPS; SWINE; VASODILATOR AGENTS;

EID: 0031015264     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006534-199701000-00026     Document Type: Article

References (44)

1. Murry, C. E., Jennings, R. B., and Reimer, K. A. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124, 1986.
2. Murry, C. E., Richard, V. J., Reimer, K. A., and Jennings, R. B. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ. Res. 66: 913, 1990.
3. Yellon, D. M., Alkhulaifi, A. M., Browne, E. E., and Pugsley, W. B. Ischemic preconditioning limits infarct size in the rat heart. Cardiovasc. Res. 26: 983, 1992.
4. Van Winkle, D. M., Thornton, D., Downey, D. M., and Downey, J. M. The natural history of preconditioning: Cardioprotection depends on duration of transient ischemia and time to subsequent ischemia. Coron. Artery Dis. 2: 613, 1991.
5. Li, G. C., Vasquez, J. A., Gallagher, K. P., and Lucchesi, B. R. Myocardial protection with preconditioning. Circulation 82: 609, 1990.
6. Schulz, R., Rose, J., and Heusch, G. Involvement of activation of ATP-dependent potassium channels in ischemic preconditioning in swine. Am. J. Physiol. 267: H134, 1994.
7. Pang, C. Y., Yang, R. Z., Zhong, A., et al. Acute ischemic preconditioning protects against skeletal muscle infarction in the pig. Cardiovasc. Res. 29: 782, 1995.
8. Downey, J. M., Cohen, M. V., Ytrehus, K., and Liu, Y. Cellular mechanisms in ischemic preconditioning: The role of adenosine and protein kinase C. Ann. N.Y. Acad. Sci. 723: 82, 1994.
9. Reimer, K. A., Vander Heide, R. S., and Jennings, R. B. Ischemic preconditioning slows ischemic metabolism and limits myocardial infarct size. Ann. N.Y. Acad. Sci. 723: 99, 1994.
10. 1 adenosine receptors in rabbit heart. Circulation 84: 350, 1991.
11. Toombs, C. F., McGee, D. S., Johnston, W. E., and Vinter-Johansen, J. Myocardial protective effects of adenosine: Infarct size reduction with pretreatment and continued receptor stimulation during ischemia. Circulation 86: 986, 1992.
12. ATP channels. Circulation 89: 1229, 1994.
13. ATP channel. Am. J. Physiol. 266: H829, 1994.
14. Li, Y., and Kloner, R. A. The cardioprotective effects of ischemic preconditioning are not mediated by adenosine receptors in rat hearts. Circulation 87: 1642, 1993.
15. Ikonomidis, J. S., Tumiati, L. C., Weisel, R. D., et al. Preconditioning human ventricular cardiomyocytes with brief periods of simulated ischemia. Cardiovasc. Res. 28: 1285, 1994.
16. 1 receptor dependent (Abstract 2564). Circulation 90: 1477, 1994.
17. Pang, C. Y., and Forrest, C. R. Acute pharmacologic preconditioning as a new concept and alternative approach for prevention of skeletal muscle ischemic necrosis. Biochem. Pharmacol. 49: 1023, 1995.
18. Kuzon, W. M., Jr., Walker, P. M., Mickle, D. A. G., et al. An isolated skeletal muscle model suitable for acute ischemic studies. J. Surg. Res. 41: 24, 1986.
19. Kerrigan, C. L., Zelt, R. G., Thomson, J. G., and Diano, E. The pig as an experimental animal in plastic surgery research for the study of skin flaps, myocutaneous flaps, and fasciocutaneous flaps. Lab. Anim. Sci. 36: 408, 1986.
20. Labbe, R., Lindsay, T., Gatley, R., et al. Quantitation of postischemic skeletal muscle necrosis: Histochemical and radioisotope techniques. J. Surg. Res. 44: 45, 1988.
21. Lee, C., Kerrigan, C. L., and Picard-Ami, L. A., Jr. Cyclophosphamide-induced neutropenia: Effect on postischemic skin-flap survival. Plast. Reconstr. Surg. 89: 1092, 1992.
22. Dorion, D., Zhong, A., Chiu, C., et al. Role of xanthine oxidase in reperfusion injury of ischemic skeletal muscles in the pig and human. J. Appl. Physiol. 75: 246, 1993.
23. Morris, S. F., Pang, C. Y., Zhong, A., et al. Assessment of ischemia-induced reperfusion injury in the pig latissimus dorsi myocutaneous flap model. Plast. Reconstr. Surg. 92: 1162, 1993.
24. Pang, C. Y., Neligan, P., and Nakatsuka, T. Assessment of microsphere technique for measurement of capillary blood flow in skin flaps in pigs. Plast. Reconstr. Surg. 74: 513, 1984.
25. Neligan, P., Pang, C. Y., Nakatsuka, T., et al. Pharmacologic action of isoxsuprine in cutaneous and myocutaneous flaps. Plast. Reconstr. Surg. 75: 363, 1985.
26. Vander Heide, R. S., Reimer, K. A., and Jennings, R. B. Adenosine slows ischemic metabolism in canine myocardium in vitro: Relationship to ischemic preconditioning. Cardiovasc. Res. 27: 669, 1993.
27. Kida, M., Fujiwara, H., Ishida, M., Kawai, C., et al. Ischemic preconditioning preserves creatine phosphate and intracellular pH. Circulation 84: 2495, 1991.
28. de Albuquerque, C. P., Gerstenblith, G., and Weiss, R. G. Importance of metabolic inhibition and cellular pH in mediating preconditioning contractile and metabolic effects in rat hearts. Circ. Res. 74: 139, 1994.
29. Steenbergen, C., Perlman, M. E., London, R. E., and Murphy, E. Mechanism of preconditioning-ionic alterations. Circ. Res. 72: 112, 1993.
30. Romano, F. D., MacDonald, S. G., and Dobson, J. G. Adenosine receptor coupling to adenylate cyclase of rat ventricular myocyte membranes. Am. J. Physiol. 257: H1088, 1989.
31. + channels in cardiac muscle. Nature 305: 147, 1983.
32. 1 receptors by G-proteins in rat ventricular myocytes. Am. J. Physiol. 259: H820, 1990.
33. + channels protect the myocardium against ischemia reperfusion damage. Circ. Res. 69: 571, 1991.
34. + channels involves high energy phosphate preservation. Am. J. Physiol. 265: H1809, 1993.
35. Ytrehus, K., Liu, Y., and Downey, J. M. Preconditioning rabbit heart by protein kinase C activation. Am. J. Physiol. 266: H1145, 1994.
36. 1) receptors in acute ischemic preconditioning against skeletal muscle infarction. Can. J. Physiol. Pharmacol. 72 (Suppl I): 146, 1994.
37. ATP) channels in ischemic preconditioning (IPC) of pig skeletal muscles. FASEB J. 9: A422, 1995.
38. Wakade, A. R., and Wakade, T. D. Inhibition of noradrenaline release by adenosine. J. Physiol. (Lond.) 282: 35, 1978.
39. Schomig, A. Catecholamines in myocardial ischemia: Systemic and cardiac release. Circulation 82 (Suppl. II): 13, 1990.
40. Richardt, G., Wass, W., Kranzhofer, R., et al. Interaction between the release of adenosine and noradrenaline during sympathetic stimulations: A feed-back mechanism in rat heart. J. Mol. Cell. Cardiol. 21: 269, 1989.
41. Belardinelli, L., Linden, J., and Berne, R. M. The cardiac effects of adenosine. Prog. Cardiovasc. Dis. 32: 73, 1989.
42. Ely, S. W., and Berne, R. M. Protective effects of adenosine in myocardial ischemia. Circulation 85: 893, 1992.
43. 2 generation, respectively. J. Clin. Invest. 85: 1150, 1990.
44. Pitary, C. J., Virmani, R., Vildibill, H. D., Jr., et al. Reduction of myocardial reperfusion injury by intravenous adenosine administered during the early reperfusion period. Circulation 83: 237, 1991.